1. Home
  2. DCTH vs CAN Comparison

DCTH vs CAN Comparison

Compare DCTH & CAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • CAN
  • Stock Information
  • Founded
  • DCTH 1988
  • CAN 2013
  • Country
  • DCTH United States
  • CAN Singapore
  • Employees
  • DCTH 76
  • CAN N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • CAN Semiconductors
  • Sector
  • DCTH Health Care
  • CAN Technology
  • Exchange
  • DCTH Nasdaq
  • CAN Nasdaq
  • Market Cap
  • DCTH 426.3M
  • CAN 384.3M
  • IPO Year
  • DCTH N/A
  • CAN 2019
  • Fundamental
  • Price
  • DCTH $11.52
  • CAN $0.73
  • Analyst Decision
  • DCTH Strong Buy
  • CAN Strong Buy
  • Analyst Count
  • DCTH 4
  • CAN 6
  • Target Price
  • DCTH $24.00
  • CAN $2.67
  • AVG Volume (30 Days)
  • DCTH 850.4K
  • CAN 28.1M
  • Earning Date
  • DCTH 08-04-2025
  • CAN 08-14-2025
  • Dividend Yield
  • DCTH N/A
  • CAN N/A
  • EPS Growth
  • DCTH N/A
  • CAN N/A
  • EPS
  • DCTH N/A
  • CAN N/A
  • Revenue
  • DCTH $53,850,000.00
  • CAN $317,009,000.00
  • Revenue This Year
  • DCTH $155.42
  • CAN $160.28
  • Revenue Next Year
  • DCTH $37.93
  • CAN $35.68
  • P/E Ratio
  • DCTH N/A
  • CAN N/A
  • Revenue Growth
  • DCTH 1068.87
  • CAN 65.68
  • 52 Week Low
  • DCTH $7.17
  • CAN $0.53
  • 52 Week High
  • DCTH $18.23
  • CAN $3.27
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 32.83
  • CAN 56.25
  • Support Level
  • DCTH $12.11
  • CAN $0.67
  • Resistance Level
  • DCTH $14.15
  • CAN $0.77
  • Average True Range (ATR)
  • DCTH 0.57
  • CAN 0.05
  • MACD
  • DCTH -0.16
  • CAN 0.01
  • Stochastic Oscillator
  • DCTH 9.67
  • CAN 72.01

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

About CAN Canaan Inc.

Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment as well as the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts.

Share on Social Networks: